Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delavirdine, Indinavir, and Zidovudine BID vs TID in HIV
NCT00002236Phase 2Completed
- Sponsor
- Pfizer
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of delavirdine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Pfizer. Status: completed.
02
Drugs
delavirdine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002236.